SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-10-123470
Filing Date
2010-05-18
Accepted
2010-05-18 17:26:05
Documents
10
Period of Report
2010-03-31
Filing Date Changed
2010-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 351873
2 FORM OF WARRANT dex43.htm EX-4.3 52708
3 SECURITIES PURCHASE AGREEMENT dex106.htm EX-10.6 362806
4 OFFICE LEASE dex1010.htm EX-10.10 5931
5 SECURITIES PURCHASE AGREEMENT dex1011.htm EX-10.11 317582
6 FORM OF REGISTRATION RIGHTS AGREEMENT dex1012.htm EX-10.12 35335
7 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6755
8 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6754
9 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 3137
10 CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 3135
  Complete submission text file 0001193125-10-123470.txt   1147773
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-17264-NY | Film No.: 10843509
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1